Abera Bioscience AB (NGM: ABERA)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.930
+0.070 (1.81%)
At close: Jan 28, 2025

Abera Bioscience AB Revenue

Abera Bioscience AB had revenue of 3.35M SEK in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to 12.60M, down -395,817.71% year-over-year. In the year 2023, Abera Bioscience AB had annual revenue of 2.52M with 41.21% growth.

Revenue (ttm)
12.60M
Revenue Growth
-395,817.71%
P/S Ratio
4.54
Revenue / Employee
2.10M
Employees
6
Market Cap
60.80M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.52M736.79K41.21%
Dec 31, 20221.79M609.91K51.78%
Dec 31, 20211.18M422.43K55.92%
Dec 31, 2020755.48K-745.52K-49.67%
Dec 31, 20191.50M-514.72K-25.54%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Investor AB 176.78B
Atlas Copco AB 176.77B
AB Volvo 526.82B
EQT AB 30.40B
ASSA ABLOY AB 147.56B
Skandinaviska Enskilda Banken AB 81.00B
Hexagon AB 60.95B
Sandvik AB 122.88B
Revenue Rankings